Last update : 01/01/2018 | Version : 1 | ID : 117
General | |
Identification | |
Detailed name | Cross-sectional Study on Migraine Patients in Emergency Service Departments: Diagnosis and Treatment |
Sign or acronym | EMU |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL no. 906286 |
General Aspects | |
Medical area |
Emergency medicine Neurology |
Keywords | emergency services |
Scientific investigator(s) (Contact) | |
Name of the director | Grun-Overdyking |
Surname | Aurélie |
Address | 23-25, avenue du dr Lannelongue, 75668 Paris cedex 14 |
Phone | +33 (0)1 58 07 33 02 |
aurelie.grun-overdyking@pfizer.com | |
Unit | Pfizer |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Pfizer |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Pfizer |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Recruitment by participating doctors |
Database objective | |
Main objective |
Primary:
- To estimate the frequency of patients admitted with headaches and to estimate the frequency of patients diagnosed with migraine. - To characterise patients diagnosed with migraines attending emergency services based on demographic data and migraine history (age, severity). - To describe the treatment of patients diagnosed with a migraine during emergency service consultation. Secondary: - To describe the treatment of patients diagnosed with a migraine according to the type of migraine. - To describe the frequency of patients diagnosed with a migraine and their treatment by emergency structure type. - To describe treatment follow-up. |
Inclusion criteria |
- Patients aged 18 or older.
- Patients deemed capable of answering the questions. - Patients agreeing to participate in the survey. - Patients admitted to emergency department |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | Metropolitan France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2006 |
Date of last collection (YYYY or MM/YYYY) | 2008 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 479 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Declarative data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Face to face interview |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Data collection method | Paper CRF |
Participant monitoring |
Yes |
Details on monitoring of participants | 6-8 weeks |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Submission of project to the Pfizer scientific team. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05